David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
NRG Energy
NRG
$23.8B
| $45.5M | 0.07% |
1,668,053
-22,950
| -1% | -$791K |
|
|
302
PUT
Pfizer
PFE
$160B
| $45.3M | 0.07% |
1,462,109
+273,935
| +23% | +$9.33M |
|
303
Graphic Packaging
GPK
$3.54B
| $45.2M | 0.07% |
3,705,494
-2,983
| -0.1% | -$43.9K |
|
304
Parker-Hannifin
PH
$126B
| $44.6M | 0.07% |
+343,830
| New | +$62.2M |
|
305
Royal Caribbean
RCL
$78.1B
| $44.5M | 0.07% |
1,383,812
-1,664,612
| -55% | -$152M |
|
306
Alcon
ALC
$35.6B
| $44.5M | 0.07% |
875,031
-374,627
| -30% | -$21.5M |
|
307
PTC Therapeutics
PTCT
$5.83B
| $44.4M | 0.07% |
995,970
-64,616
| -6% | -$3.25M |
|
308
Commault Systems
CVLT
$5.55B
| $44.4M | 0.07% |
1,096,113
-124,296
| -10% | -$5.37M |
|
309
Vanguard Real Estate ETF
VNQ
$39.1B
| $44.3M | 0.07% |
634,682
-839,280
| -57% | -$73.7M |
|
|
TWTR
310
DELISTED
Twitter, Inc.
TWTR
| $44.3M | 0.07% |
1,803,368
-3,632,803
| -67% | -$118M |
|
311
PUT
AbbVie
ABBV
$468B
| $44.1M | 0.07% |
578,500
-21,800
| -4% | -$1.86M |
|
312
Incyte
INCY
$25.9B
| $43.8M | 0.07% |
598,144
-226,540
| -27% | -$17.1M |
|
|
DCUE
313
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $43.6M | 0.07% |
465,000
+150,000
| +48% | +$15.6M |
|
314
Royal Gold
RGLD
$21.9B
| $43.5M | 0.07% |
496,488
+492,939
| +13,890% | +$50.9M |
|
315
Magna International
MGA
$19.5B
| $43.5M | 0.07% |
1,362,283
+833,664
| +158% | +$38.5M |
|
316
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $42.8M | 0.07% |
87,600
-58,400
| -40% | -$24.1M |
|
317
Kinder Morgan
KMI
$69B
| $42.7M | 0.07% |
3,064,031
-687,372
| -18% | -$13.1M |
|
318
Textron
TXT
$14.3B
| $42.6M | 0.07% |
1,596,128
-322,999
| -17% | -$13M |
|
319
Zimmer Biomet
ZBH
$19.3B
| $42.4M | 0.07% |
431,971
+290,070
| +204% | +$38M |
|
320
DTE Energy
DTE
$28.1B
| $42.4M | 0.07% |
524,010
+395,666
| +308% | +$40.2M |
|
321
Bunge Global
BG
$21.7B
| $42.3M | 0.07% |
1,030,304
+809,570
| +367% | +$39.6M |
|
|
CXO
322
DELISTED
CONCHO RESOURCES INC.
CXO
| $42M | 0.07% |
981,267
+953,767
| +3,468% | +$66.4M |
|
323
PUT
Caterpillar
CAT
$381B
| $41.8M | 0.07% |
360,400
-488,500
| -58% | -$62.4M |
|
324
Gen Digital
GEN
$17.3B
| $41.7M | 0.07% |
2,227,014
-3,361,704
| -60% | -$72.7M |
|
325
Herbalife
HLF
$1.33B
| $41.6M | 0.07% |
1,427,954
-1,655,709
| -54% | -$61.6M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.